NDLI: BAG1 is Neuroprotective in In Vivo and In Vitro Models of Parkinson’s Disease

Content Provider	Springer Nature Link
Author	Kermer, Pawel Köhn, Anja Schnieder, Marlena Lingor, Paul Bähr, Mathias Liman, Jan Dohm, Christoph Peter
Copyright Year	2014
Abstract	Bcl-2-associated athanogene-1 (BAG1) is a multifunctional protein comprising co-chaperone function, increasing Hsp70 foldase activity and chaperone-dependent protein degradation of misfolded substrates, with anti-apoptotic activity. It is neuroprotective in different models of neurological diseases, like cerebral ischemia and Huntington’s disease. In the context of Parkinson’s disease, it has recently been shown to restore DJ-1 function in an in vitro model of hereditary Parkinson’s disease. Here, we demonstrate that BAG1 overexpression in SH-SY5Y cells reduces toxicity after transfection of disease-related α-synuclein mutants. Furthermore, it protects from rotenone-induced cell death in vitro and ameliorates neuronal demise in an in vivo 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (MPTP) model for Parkinson’s disease after adeno-associated virus (AAV)-mediated BAG1 gene transfer into the substantia nigra in mice but showed no protective effects in an in vitro 6-hydroxidopamine model. In conclusion, we present BAG1 as a potential therapeutic target in Parkinson’s disease.
Starting Page	587
Ending Page	595
Page Count	9
File Format	PDF
ISSN	08958696
Journal	Journal of Molecular Neuroscience
Volume Number	55
Issue Number	3
e-ISSN	15591166
Language	English
Publisher	Springer US
Publisher Date	2014-08-09
Publisher Place	Boston
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	BAG1 Parkinson’s disease α-Synuclein Rotenone 6-Hydroxydopamine MPTP Neurosciences Neurochemistry Cell Biology Proteomics Neurology
Content Type	Text
Resource Type	Article
Subject	Medicine Cellular and Molecular Neuroscience

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

SIRT3 Acts as a Neuroprotective Agent in Rotenone-Induced Parkinson Cell Model

Neurotoxin Mechanisms and Processes Relevant to Parkinson’s Disease: An Update

Models of α-synuclein aggregation in Parkinson’s disease

Knocking Out DJ-1 Attenuates Astrocytes Neuroprotection Against 6-Hydroxydopamine Toxicity

Molecular and Neurochemical Mechanisms in PD Pathogenesis

Neuroprotective Role of MicroRNA-22 in a 6-Hydroxydopamine-Induced Cell Model of Parkinson’s Disease via Regulation of Its Target Gene TRPM7

Valproic Acid is Neuroprotective in the Rotenone Rat Model of Parkinson’s Disease: Involvement of α-Synuclein

Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders

Pramipexole Reduces Phosphorylation of α-Synuclein at Serine-129

BAG1 is Neuroprotective in In Vivo and In Vitro Models of Parkinson’s Disease

Similar Documents

SIRT3 Acts as a Neuroprotective Agent in Rotenone-Induced Parkinson Cell Model

Neurotoxin Mechanisms and Processes Relevant to Parkinson’s Disease: An Update

Models of α-synuclein aggregation in Parkinson’s disease

Knocking Out DJ-1 Attenuates Astrocytes Neuroprotection Against 6-Hydroxydopamine Toxicity

Molecular and Neurochemical Mechanisms in PD Pathogenesis

Neuroprotective Role of MicroRNA-22 in a 6-Hydroxydopamine-Induced Cell Model of Parkinson’s Disease via Regulation of Its Target Gene TRPM7

Valproic Acid is Neuroprotective in the Rotenone Rat Model of Parkinson’s Disease: Involvement of α-Synuclein

Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders

Pramipexole Reduces Phosphorylation of α-Synuclein at Serine-129

BAG1 is Neuroprotective in In Vivo and In Vitro Models of Parkinson’s Disease